India, with its diverse climatic conditions, is a fertile ground for multiple vector-borne diseases (VBDs). These diseases represent a significant public health challenge, affecting millions annually.
Among the VBDs, malaria, dengue, and chikungunya are the most prevalent. The National Vector Borne Disease Control Programme (NVBDCP) reports over 4 lakh malaria cases annually. Dengue, with its increasing incidence, has been reported in all states, while chikungunya has re-emerged with several outbreaks in the last decade.
VBDs pose a significant burden on India's public health system. They lead to high morbidity and mortality rates, straining health infrastructure and causing substantial economic losses. The indirect impact includes productivity loss due to illness and the social stigma associated with these diseases.
Management of VBDs involves vector control, early case detection, and prompt treatment. Vector control includes environmental management, insecticide-treated nets, and indoor residual spraying. Early case detection and prompt treatment are facilitated by strengthening surveillance systems and improving diagnostic facilities. The NVBDCP plays a crucial role in implementing these strategies.
Despite efforts, controlling VBDs remains a challenge due to factors like urbanization, climate change, and insecticide resistance. Future strategies should focus on integrated vector management, community participation, and leveraging technology for surveillance and vector control. More research is needed to develop effective vaccines and novel vector control methods.
Vector-borne diseases continue to pose a significant public health challenge in India. Comprehensive strategies focusing on prevention, early detection, and prompt treatment are vital. Further, integrating research, policy, and practice can help mitigate the impact of these diseases and improve public health outcomes.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation